La Renon

Ahmedabad, India Founded: 2007 • Age: 19 yrs
Pharmaceutical products for chronic disease management are provided.
Annual revenue $140.4M Latest available
Total funding $115.6M 3 rounds
Employees 2727 Tracked headcount
Investors 3 Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About La Renon

La Renon is a company based in Ahmedabad (India) founded in 2007 by Pankaj Singh. La Renon has raised $115.63 million across 3 funding rounds from investors including Peak XV Partners, A91 Partners and ChrysCapital. The company has 2,727 employees as of February 25, 2025. La Renon has completed 1 acquisition, including Enaltec Labs. La Renon offers products and services including Nephroscience Products and Critical Care Products.

  • Headquarter Ahmedabad, India
  • Employees 2727 as on 25 Feb, 2025
  • Founders Pankaj Singh
  • Stage Minicorn
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name La Renon Healthcare Private Limited
  • Date of Incorporation 07 Aug, 2007
  • Jurisdiction Ahmedabad, Gujarat, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $140.44 M (USD)
    37.57
    as on Mar 31, 2023
  • Net Profit
    $14.09 M (USD)
    -1.04
    as on Mar 31, 2023
  • EBITDA
    $23.47 M (USD)
    13.69
    as on Mar 31, 2023
  • Total Equity Funding
    $115.63 M (USD)

    in 3 rounds

  • Latest Funding Round
    $70 M (USD), Series C

    Apr 24, 2024

  • Investors
  • Employee Count
    2727

    as on Feb 25, 2025

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of La Renon

La Renon offers a comprehensive portfolio of products and services, including Nephroscience Products and Critical Care Products.

Product name locked
Category locked
Primary

Products for chronic kidney disease management are provided in the therapeutic segment

Product name locked
Category locked
Locked

High-quality anti-infectives for ICUs and trauma centers are supplied across India

People of La Renon

Headcount 500-1000
Employee Profiles 5
Employee Profiles
People
Samir Kumar
Senior Vice President
People
Pankaj Singh
Chairman & Managing Director
People
Vivek Gupta
Senior Vice President
People
Yashwant Singh
Senior Vice President

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of La Renon

La Renon has successfully raised a total of $115.63M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $70 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in La Renon

La Renon has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Peak XV Partners, A91 Partners and ChrysCapital.

All
Venture Fund
Investor Description Founded Year Domain Location
Investment partnerships and support for founders in software, financial services, and consumer sectors.
Locked Locked Locked
Venture capital firm investing in startups and providing support programs.
Locked Locked Locked
Investment firm focusing on private equity in sectors like financial services and healthcare.
Locked Locked Locked
Premium access

Investor details for La Renon

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by La Renon

La Renon has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Enaltec Labs.

Investments
Premium access

Investment portfolio details for La Renon

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Non-oncology APIs are developed and manufactured by Enaltec Labs.
Locked Locked 2006 Locked
Premium access

Complete acquisition details for La Renon

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - La Renon

Premium access

Detailed financials for La Renon

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

La Renon Comparisons

La Renon Primary company
Description
Pharmaceutical products for chronic disease management are p...
Location
Ahmedabad, India
Founded Year
2007
Annual Revenue
$140.44 M (USD)
Net Profit
$14.09 M (USD)
EBITDA
$23.47 M (USD)
Employees
2,727
As of 2025
Premium access

Peer comparison for La Renon

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of La Renon

Premium access

Detailed competitors of La Renon

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on La Renon

Premium access

Complete news archive for La Renon

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about La Renon

La Renon was founded in 2007 and raised its 1st funding round 8 years after it was founded.

La Renon is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

Pankaj Singh is the current CEO of La Renon. They have also founded this company.

La Renon is a funded company, having raised a total of $115.63M across 3 funding rounds to date.

As of Feb 25, 2025, the latest employee count at La Renon is 2,727.

Annual revenue of La Renon is $140.44M as on Mar 31, 2023.

La Renon was founded in 2007 in Ahmedabad, India, as a provider of pharmaceutical products. Operations are centered on chronic disease management across therapeutic areas including nephrology, neurology, urology, critical care, gastroenterology, respiratory, and cardiac metabolism such as hypertension and diabetes. A CNS division addresses severe conditions like epilepsy, Alzheimers, Parkinsons, and neuropathic pain. The company operates within the healthcare sector, focusing on product development and distribution.

La Renon offers Nephroscience Products and Critical Care Products.

La Renon has made 1 acquisition, including Enaltec Labs.

La Renon has 3 investors. Key investors include Peak XV Partners, A91 Partners, and ChrysCapital.

The valuation of La Renon is $124.64M as of Jun 2015.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available